Anaphylactic reaction to polyethylene-glycol conjugated-asparaginase: premedication and desensitization may not be sufficient

Pediatr Int. 2013 Aug;55(4):531-3. doi: 10.1111/ped.12131.

Abstract

In hypersensitive reactions to native L-asparaginase, either premedication and desensitization or substitution with polyethylene glycol conjugated asparaginase (PEG-ASP) is preferred. Anaphylaxis with PEG-ASP is rare. An 8-year-old girl and a 2.5-year-old boy, both diagnosed as having acute lymphoblastic leukemia, presented with native L-asparaginase hypersensitivity and substitution with PEG-ASP was preferred. They received a premedication (methylprednisolone, hydroxyzine and ranitidine) followed by desensitization with PEG-ASP infusion. Both patients developed anaphylaxis with peg-asparaginase. These are the first reported cases of anaphylactic reaction to PEG-ASP, despite the application of both premedication and desensitization. Anaphylaxis with PEG-ASP is very rare and premedication and desensitization protocols may not prevent these hypersensitive reactions.

Keywords: anaphylaxis; desensitization; hypersensitivity; polyethylene-glycol asparaginase; premedication.

Publication types

  • Case Reports

MeSH terms

  • Anaphylaxis / chemically induced*
  • Anaphylaxis / prevention & control
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Asparaginase / adverse effects*
  • Asparaginase / therapeutic use
  • Child
  • Child, Preschool
  • Delayed-Action Preparations
  • Desensitization, Immunologic / methods*
  • Female
  • Humans
  • Male
  • Polyethylene Glycols / adverse effects*
  • Polyethylene Glycols / therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Premedication / methods*

Substances

  • Antineoplastic Agents
  • Delayed-Action Preparations
  • Polyethylene Glycols
  • pegaspargase
  • Asparaginase